Hebei Changshan Biochem Pharma (300255) — Cash Flow-to-Debt Ratio
Hebei Changshan Biochem Pharma (300255) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of CN¥-30.86 Million could theoretically repay 0% of its total liabilities (CN¥3.18 Billion) in one year. See how much free cash does Hebei Changshan Biochem Pharma generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hebei Changshan Biochem Pharma Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Hebei Changshan Biochem Pharma across 17 annual periods. Also explore 300255 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hebei Changshan Biochem Pharma (2008–2024)
Year-by-year debt coverage analysis for Hebei Changshan Biochem Pharma. For market capitalisation and broader financial context, see market cap of Hebei Changshan Biochem Pharma.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CN¥56.22 Million | CN¥2.99 Billion | ▲ +56.1% |
| 2023 | 0.01x | CN¥33.73 Million | CN¥2.80 Billion | ▲ +1050.4% |
| 2022 | 0.00x | CN¥3.13 Million | CN¥2.98 Billion | ▼ -22.7% |
| 2021 | 0.00x | CN¥2.87 Million | CN¥2.12 Billion | ▲ +101.3% |
| 2020 | -0.11x | CN¥-183.58 Million | CN¥1.72 Billion | ▼ -124.2% |
| 2019 | -0.05x | CN¥-58.13 Million | CN¥1.22 Billion | ▼ -121.5% |
| 2018 | 0.22x | CN¥292.81 Million | CN¥1.32 Billion | ▲ +49.4% |
| 2017 | 0.15x | CN¥162.28 Million | CN¥1.09 Billion | ▼ -27.4% |
| 2016 | 0.20x | CN¥171.96 Million | CN¥842.59 Million | ▲ +505.1% |
| 2015 | -0.05x | CN¥-38.14 Million | CN¥757.07 Million | ▲ +63.4% |
| 2014 | -0.14x | CN¥-84.97 Million | CN¥617.87 Million | ▼ -224.5% |
| 2013 | -0.04x | CN¥-15.24 Million | CN¥359.78 Million | ▲ +82.4% |
| 2012 | -0.24x | CN¥-70.62 Million | CN¥292.77 Million | ▼ -381.4% |
| 2011 | 0.09x | CN¥17.04 Million | CN¥198.78 Million | ▼ -38.1% |
| 2010 | 0.14x | CN¥29.25 Million | CN¥211.25 Million | ▼ -38.7% |
| 2009 | 0.23x | CN¥24.21 Million | CN¥107.15 Million | ▲ +175.6% |
| 2008 | -0.30x | CN¥-30.83 Million | CN¥103.16 Million | — |